InterVenn Biosciences advances glycoproteomics for complex disease therapies

US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...

January 17, 2020 | Friday | News
AVROBIO announces clinical and regulatory progress for Gaucher Disease Program

US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic...

January 17, 2020 | Friday | News
Agilex Biolabs announces new pharmacodynamics services

Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, ...

January 15, 2020 | Wednesday | News
Australia explores novel way to detect infections and cancers

Melbourne researchers have determined the molecular basis for how an important component of the immune system, called ga...

January 13, 2020 | Monday | News
Griffith University to develop new drug for parainfluenza virus

Australia based Griffith University’s Institute for Glycomics has partnered with Hong Kong listed China ...

January 6, 2020 | Monday | News
AlayaCare acquires Procura to strengthen its healthcare platform

AlayaCare, an award-winning technology platform for home and community care, has announced the acquisition of Procura, a...

January 3, 2020 | Friday | News
Avita Medical gets FDA approval for Recell device

UK based AVITA Medical Limited, a regenerative medicine company with a technology platform positioned to address unmet m...

January 3, 2020 | Friday | News
Genetic data offers risk indications for ischaemic stroke

A group of investigators from Australia, Germany, and the UK have shown that genetic data obtained from a single blood d...

January 1, 2020 | Wednesday | News
Adelaide researchers to develop novel Zika vaccine

Researchers from the University of Adelaide, Australia have made significant advances in developing a novel vaccine agai...

December 30, 2019 | Monday | News
Investors inject $45M into South Australia biotech industry

The Adelaide China Biotech Investment Fund has been launched – a new $45 million investment fund that will acceler...

December 27, 2019 | Friday | News
Glenmark announces approval for Ryaltris in Australia

Glenmark Pharmaceuticals has announced that Seqirus Pty. Ltd. (Seqirus) has received marketing approval for Ryaltris®...

December 23, 2019 | Monday | News
Australia's MRCF leads $8.8M funding for Pathios Therapeutics

UK based Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therap...

December 20, 2019 | Friday | News
Biocon & Equillium expand collaboration to Australia, NZ

India headquartered Biocon Ltd and US based Equillium Inc., a clinical-stage biotechnology company leveraging deep under...

December 13, 2019 | Friday | News
NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar

NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...

December 13, 2019 | Friday | News
Mainstay Medical receives approval for ReActiv8 from Australian TGA

Ireland based medical device company Mainstay Medical International plc has announced that it has received regulatory ap...

December 11, 2019 | Wednesday | News
Novotech collaborates with PPC Group

Novotech and PPC Group (PPC), two leading, Asia-Pacific contract research organisations (CROs), have formed a strat...

December 3, 2019 | Tuesday | News
Vaccitech provides update for its Phase 2 Universal Influenza studies

Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infecti...

November 25, 2019 | Monday | News
Indian traditional medicine legacy reaches Australia

All India Institute of Ayurveda (AIIA) has signed a Memorandum of Understanding with Western Sydney University, Australi...

November 25, 2019 | Monday | News